Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.43 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 12/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.36 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833317 | 0.87 | BCAT2 (0.46) | FNTAFNTBPGGT1BPLA2G7MEN1 | |
| SCHEMBL8194251 | 0.82 | POLB (0.47) | FNTAFNTBPGGT1BARGAA | |
| SCHEMBL6694769 | 0.78 | GAA (0.53) | FNTAFNTBPGGT1BPLA2G7MEN1 | |
| SCHEMBL8485509 | 0.76 | GAA (0.51) | MEN1NPC1RAB9AKMT2ACA1 | |
| SCHEMBL7021135 | 0.72 | SLC22A12 (0.40) | ARGAABCAT2BCAT1 | |
| SCHEMBL8132627 | 0.71 | GAA (0.62) | FNTAFNTBPGGT1BPLA2G7MEN1 | |
| SCHEMBL6594425 | 0.70 | TRPV4 (0.47) | AR | |
| SCHEMBL6690921 | 0.69 | NLRP3 (0.46) | FNTAFNTBPGGT1BPLA2G7MEN1 | |
| SCHEMBL20510954 | 0.69 | ALDH1A1 (0.57) | FNTAFNTBPGGT1BPLA2G7MEN1 | |
| SCHEMBL30360773 | 0.69 | ALDH1A1 (0.57) | FNTAFNTBPGGT1BPLA2G7MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029735-A1 | Substituted herbicidal phenyluracils | ANDREE ROLAND (DE) | 2004-02-12 | — | — | US | disclosed |
| US-6624120-B1 | Such as 1-(4-cyano-2-fluoro-5-(6-methoxy-naphthalen-2-yl-oxy)-phenyl)-2,6-dioxo -1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid | BAYER AKTIENGESELLSCHAFT (DE) | 2003-09-23 | — | — | US | disclosed |
| EP-1192140-A1 | SUBSTITUTED HERBICIDAL PHENYLURACILS | Bayer Aktiengesellschaft (DE) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000078734-A1 | SUBSTITUTED HERBICIDAL PHENYLURACILS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029735-A1 | Substituted herbicidal phenyluracils | DDT, MTX1, MTX2 | FNTA 2427/4885FNTB 1181/4885PGGT1B 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.